Reuters
The Food and Drug Administration (news - web sites) last year denied a request by Barr Pharmaceuticals Inc.'s to sell the contraceptive, called Plan B, over the counter. That sparked a furor over whether the decision was based on scientific evidence or political considerations.
FDA (news - web sites) officials cited a lack of information on whether girls under 16 could use the drug safely without a doctor's input. That prompted Barr to refile its request that the pill be made be available without prescription to patients 16 and older.
More...
|
